151 related articles for article (PubMed ID: 28643375)
21. Evaluating an easy sampling method using dried blood spots to determine vedolizumab concentrations.
Bian S; Van den Berghe N; Vandersmissen L; Tops S; Vermeire S; Ferrante M; Gils A; Thomas D
J Pharm Biomed Anal; 2020 Jun; 185():113224. PubMed ID: 32151929
[TBL] [Abstract][Full Text] [Related]
22. Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia.
Giles FJ; Yin OQ; Sallas WM; le Coutre PD; Woodman RC; Ottmann OG; Baccarani M; Kantarjian HM
Eur J Clin Pharmacol; 2013 Apr; 69(4):813-23. PubMed ID: 23052406
[TBL] [Abstract][Full Text] [Related]
23. Mercury Speciation in Whole Blood and Dried Blood Spots from Capillary and Venous Sources.
Santa-Rios A; Barst BD; Basu N
Anal Chem; 2020 Mar; 92(5):3605-3612. PubMed ID: 32056420
[TBL] [Abstract][Full Text] [Related]
24. Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti-adalimumab in patients with inflammatory diseases.
Kneepkens EL; Pouw MF; Wolbink GJ; Schaap T; Nurmohamed MT; de Vries A; Rispens T; Bloem K
Br J Clin Pharmacol; 2017 Nov; 83(11):2474-2484. PubMed ID: 28791718
[TBL] [Abstract][Full Text] [Related]
25. Dried blood spot versus venous blood sampling for phenylalanine and tyrosine.
van Vliet K; van Ginkel WG; van Dam E; de Blaauw P; Koehorst M; Kingma HA; van Spronsen FJ; Heiner-Fokkema MR
Orphanet J Rare Dis; 2020 Apr; 15(1):82. PubMed ID: 32245393
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of a dried blood spot method for determination of mycophenolic acid in renal transplant patients.
Arpini J; Antunes MV; Pacheco LS; Gnatta D; Rodrigues MF; Keitel E; Linden R
Clin Biochem; 2013 Dec; 46(18):1905-8. PubMed ID: 24161478
[TBL] [Abstract][Full Text] [Related]
27. Analysis of ochratoxin A in dried blood spots - Correlation between venous and finger-prick blood, the influence of hematocrit and spotted volume.
Osteresch B; Cramer B; Humpf HU
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1020():158-64. PubMed ID: 27046696
[TBL] [Abstract][Full Text] [Related]
28. The Use of Dried Blood Spots for Pharmacokinetic Monitoring of Vemurafenib Treatment in Melanoma Patients.
Nijenhuis CM; Huitema AD; Marchetti S; Blank C; Haanen JB; van Thienen JV; Rosing H; Schellens JH; Beijnen JH
J Clin Pharmacol; 2016 Oct; 56(10):1307-12. PubMed ID: 26918324
[TBL] [Abstract][Full Text] [Related]
29. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Clozapine.
Geers LM; Cohen D; Wehkamp LM; van Hateren K; Koster RA; Fedorenko OY; Semke AV; Bokhan N; Ivanova SA; Kosterink JGW; Loonen AJM; Touw DJ
J Clin Psychiatry; 2017; 78(9):e1211-e1218. PubMed ID: 29068609
[TBL] [Abstract][Full Text] [Related]
30. Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation.
Berends SE; D'Haens GRAM; Schaap T; de Vries A; Rispens T; Bloem K; Mathôt RAA
Br J Clin Pharmacol; 2019 Jul; 85(7):1544-1551. PubMed ID: 30927375
[TBL] [Abstract][Full Text] [Related]
31. Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study.
Nicolini FE; Etienne G; Dubruille V; Roy L; Huguet F; Legros L; Giraudier S; Coiteux V; Guerci-Bresler A; Lenain P; Cony-Makhoul P; Gardembas M; Hermet E; Rousselot P; Amé S; Gagnieu MC; Pivot C; Hayette S; Maguer-Satta V; Etienne M; Dulucq S; Rea D; Mahon FX
Lancet Haematol; 2015 Jan; 2(1):e37-46. PubMed ID: 26687426
[TBL] [Abstract][Full Text] [Related]
32. Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial.
Kantarjian HM; Hochhaus A; Saglio G; De Souza C; Flinn IW; Stenke L; Goh YT; Rosti G; Nakamae H; Gallagher NJ; Hoenekopp A; Blakesley RE; Larson RA; Hughes TP
Lancet Oncol; 2011 Sep; 12(9):841-51. PubMed ID: 21856226
[TBL] [Abstract][Full Text] [Related]
33. Do capillary dried blood spot concentrations of gamma-hydroxybutyric acid mirror those in venous blood? A comparative study.
Sadones N; Archer JR; Ingels AS; Dargan PI; Wood DM; Wood M; Neels H; Lambert WE; Stove CP
Drug Test Anal; 2015 Apr; 7(4):336-40. PubMed ID: 25565078
[TBL] [Abstract][Full Text] [Related]
34. Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer.
Willemsen AECAB; Knapen LM; de Beer YM; Brüggemann RJM; Croes S; van Herpen CML; van Erp NP
Eur J Clin Pharmacol; 2018 Apr; 74(4):465-471. PubMed ID: 29222715
[TBL] [Abstract][Full Text] [Related]
35. Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information.
Detrez I; Schops G; Lefrère J; Tops S; Van Assche G; Vermeire S; Van Moerkercke W; Ferrante M; Gils A
AAPS J; 2018 Dec; 21(1):10. PubMed ID: 30564993
[TBL] [Abstract][Full Text] [Related]
36. Validation and Application of a Dried Blood Spot Ceftriaxone Assay.
Page-Sharp M; Nunn T; Salman S; Moore BR; Batty KT; Davis TM; Manning L
Antimicrob Agents Chemother; 2016 Jan; 60(1):14-23. PubMed ID: 26438505
[TBL] [Abstract][Full Text] [Related]
37. Utility of Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib in Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis.
García-Ferrer M; Wojnicz A; Mejía G; Koller D; Zubiaur P; Abad-Santos F
Clin Ther; 2019 Dec; 41(12):2558-2570.e7. PubMed ID: 31812340
[TBL] [Abstract][Full Text] [Related]
38. Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: retrospective analysis of patient data from five clinical trials.
Jain P; Kantarjian H; Alattar ML; Jabbour E; Sasaki K; Nogueras Gonzalez G; Dellasala S; Pierce S; Verstovsek S; Wierda W; Borthakur G; Ravandi F; O'Brien S; Cortes J
Lancet Haematol; 2015 Mar; 2(3):e118-28. PubMed ID: 26687797
[TBL] [Abstract][Full Text] [Related]
39. Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole.
van der Elst KC; Span LF; van Hateren K; Vermeulen KM; van der Werf TS; Greijdanus B; Kosterink JG; Uges DR; Alffenaar JW
Antimicrob Agents Chemother; 2013 Oct; 57(10):4999-5004. PubMed ID: 23896473
[TBL] [Abstract][Full Text] [Related]
40. Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.
Knippenberg B; Page-Sharp M; Salman S; Clark B; Dyer J; Batty KT; Davis TM; Manning L
Antimicrob Agents Chemother; 2016 Aug; 60(8):4940-55. PubMed ID: 27270283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
